HNB
CSTL icon

Huntington National Bank’s Castle Biosciences CSTL Stock Holding History

Huntington National Bank’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.41K Hold
139
– – ﹤0.01% 2159
2025
Q4 		$5.41K Hold
139
– – ﹤0.01% 1969
2025
Q3 		$3.17K Sell
139
-58
-29% -$1.18K ﹤0.01% 2111
2025
Q2 		$4.02K Buy
197
+196
+19,600% +$3.63K ﹤0.01% 2060
2025
Q1 		$20 Hold
1
– – ﹤0.01% 3474
2024
Q4 		$27 Hold
1
– – ﹤0.01% 3341
2024
Q3 		$29 Hold
1
– – ﹤0.01% 3284
2024
Q2 		$22 Hold
1
– – ﹤0.01% 3392
2024
Q1 		$22 Hold
1
– – ﹤0.01% 3252
2023
Q4 		$22 Sell
1
-363
-100% -$6.39K ﹤0.01% 3150
2023
Q3 		$6.15K Buy
364
+6
+2% +$105 ﹤0.01% 1734
2023
Q2 		$4.91K Sell
358
-25
-7% -$507 ﹤0.01% 1813
2023
Q1 		$8.7K Buy
383
+13
+4% +$318 ﹤0.01% 1576
2022
Q4 		$8.71K Buy
370
+77
+26% +$1.78K ﹤0.01% 1531
2022
Q3 		$8K Hold
293
– – ﹤0.01% 1590
2022
Q2 		$6K Buy
293
+251
+598% +$5.83K ﹤0.01% 1682
2022
Q1 		$2K Hold
42
– – ﹤0.01% 1892
2021
Q4 		$2K Buy
+42
New +$2.19K ﹤0.01% 1878

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Huntington National Bank's CSTL Position: Q1 2026 in Review

Huntington National Bank held its Castle Biosciences (CSTL) position steady in Q1 2026 at 139 shares worth $3.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2159.

Huntington National Bank first reported a position in CSTL in Q4 2021 and has held it in 18 quarters since. The position peaked at $8.71K in Q4 2022. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Huntington National Bank held 139 shares of Castle Biosciences worth $3.41K as of Q1 2026.
  • Huntington National Bank left its Castle Biosciences share count unchanged in Q1 2026.
  • Castle Biosciences made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2159 holding.
  • Huntington National Bank first reported a position in Castle Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Huntington National Bank's Castle Biosciences position peaked at $8.71K in Q4 2022.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.